4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001209191-21-054749
Chief Technology Officer acquired 875,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Falconer Ester Chief Technology Officer | 2021-09-01 | Option exercise | +875,000 | $16.89 | $14,778,750 | 875,000 | D |
| Derivatives | |||||||
| Falconer Ester Chief Technology Officer | 2021-09-01 | Option exercise · Share option (right to buy) | −875,000 | 875,000 | D | ||
Loading xslF345X03/doc4.xml…